STAM2
Basic information
Region (hg38): 2:152116801-152175763
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STAM2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 28 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 1 | 0 |
Variants in STAM2
This is a list of pathogenic ClinVar variants found in the STAM2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-152120590-T-G | not specified | Uncertain significance (Dec 06, 2023) | ||
2-152120609-G-C | not specified | Uncertain significance (Mar 29, 2023) | ||
2-152120691-C-T | not specified | Uncertain significance (May 25, 2022) | ||
2-152120699-C-T | not specified | Uncertain significance (Oct 05, 2021) | ||
2-152120707-C-T | not specified | Uncertain significance (Dec 11, 2023) | ||
2-152120726-C-A | not specified | Uncertain significance (Aug 12, 2021) | ||
2-152120770-T-C | not specified | Uncertain significance (Jun 30, 2022) | ||
2-152120774-T-C | not specified | Uncertain significance (Aug 13, 2021) | ||
2-152123916-T-C | not specified | Uncertain significance (Apr 26, 2024) | ||
2-152126231-T-C | Likely benign (Nov 01, 2022) | |||
2-152132120-A-G | not specified | Uncertain significance (Sep 13, 2023) | ||
2-152132151-C-T | not specified | Uncertain significance (Oct 20, 2021) | ||
2-152133190-T-C | not specified | Uncertain significance (Dec 01, 2022) | ||
2-152133197-A-G | not specified | Uncertain significance (Jan 22, 2024) | ||
2-152133444-C-A | not specified | Uncertain significance (Nov 07, 2022) | ||
2-152133484-G-A | not specified | Uncertain significance (Jan 22, 2024) | ||
2-152135536-T-C | not specified | Uncertain significance (May 26, 2024) | ||
2-152135550-G-A | not specified | Uncertain significance (Mar 28, 2023) | ||
2-152135595-T-C | not specified | Uncertain significance (Sep 17, 2021) | ||
2-152135603-A-G | not specified | Likely benign (May 31, 2023) | ||
2-152143907-T-A | not specified | Uncertain significance (Mar 23, 2022) | ||
2-152143918-G-A | not specified | Uncertain significance (May 07, 2024) | ||
2-152143954-G-C | not specified | Uncertain significance (Jul 15, 2021) | ||
2-152144894-C-A | not specified | Uncertain significance (Sep 13, 2023) | ||
2-152147172-G-A | not specified | Uncertain significance (Jun 05, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STAM2 | protein_coding | protein_coding | ENST00000263904 | 14 | 59192 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000104 | 0.997 | 125676 | 0 | 72 | 125748 | 0.000286 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.348 | 253 | 269 | 0.940 | 0.0000127 | 3444 |
Missense in Polyphen | 70 | 86.922 | 0.80532 | 1138 | ||
Synonymous | 0.738 | 84 | 93.1 | 0.903 | 0.00000448 | 975 |
Loss of Function | 2.65 | 13 | 28.2 | 0.461 | 0.00000119 | 376 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000769 | 0.000759 |
Ashkenazi Jewish | 0.0000996 | 0.0000992 |
East Asian | 0.000110 | 0.000109 |
Finnish | 0.000673 | 0.000647 |
European (Non-Finnish) | 0.000284 | 0.000281 |
Middle Eastern | 0.000110 | 0.000109 |
South Asian | 0.000236 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in intracellular signal transduction mediated by cytokines and growth factors. Upon IL-2 and GM-CSL stimulation, it plays a role in signaling leading to DNA synthesis and MYC induction. May also play a role in T-cell development. Involved in down-regulation of receptor tyrosine kinase via multivesicular body (MVBs) when complexed with HGS (ESCRT-0 complex). The ESCRT-0 complex binds ubiquitin and acts as sorting machinery that recognizes ubiquitinated receptors and transfers them to further sequential lysosomal sorting/trafficking processes (By similarity). {ECO:0000250}.;
- Pathway
- Jak-STAT signaling pathway - Homo sapiens (human);Endocytosis - Homo sapiens (human);EGF-EGFR Signaling Pathway;Disease;Signal Transduction;Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Endosomal Sorting Complex Required For Transport (ESCRT);Metabolism of proteins;TCR;Infectious disease;Fibroblast growth factor-1;EGFR downregulation;Signaling by EGFR;Clathrin-mediated endocytosis;EGFR1;Ub-specific processing proteases;IL2;Deubiquitination;IL2-mediated signaling events;Cargo recognition for clathrin-mediated endocytosis;Negative regulation of MET activity;Signaling by MET;Signaling by Receptor Tyrosine Kinases;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells
(Consensus)
Recessive Scores
- pRec
- 0.234
Intolerance Scores
- loftool
- 0.763
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 27.69
Haploinsufficiency Scores
- pHI
- 0.513
- hipred
- Y
- hipred_score
- 0.822
- ghis
- 0.651
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.810
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Stam2
- Phenotype
- hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; immune system phenotype;
Gene ontology
- Biological process
- intracellular protein transport;endosomal transport;macroautophagy;multivesicular body assembly;negative regulation of epidermal growth factor receptor signaling pathway;membrane organization
- Cellular component
- nucleoplasm;cytoplasm;cytosol;early endosome membrane;ESCRT-0 complex;intracellular membrane-bounded organelle
- Molecular function
- protein binding